Close relationship between serum hyaluronan levels and vascular function in patients with type 2 diabetes

Biomarkers

Volumn 19, Issue 6, 2014, Pages 493-497

  Morita, Miwa ^a   Yano, Shozo ^a   Ishibashi, Yutaka ^a   Nakata, Noriko ^a   Kurioka, Soichi ^b   Sugimoto, Toshitsugu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b Komatsu Hospital   (Japan)

Author keywords

Diabetes; Hyaluronan; Vascular function

Indexed keywords

C REACTIVE PROTEIN; COLLAGEN TYPE 4; HEMOGLOBIN A1C; HYALURONIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD LEVEL; BLOOD VESSEL PARAMETERS; BODY MASS; CARDIOVASCULAR FUNCTION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DISEASE MARKER; ENDOTHELIUM DEPENDENT FLOW MEDIATED DILATION; ENDOTHELIUM INDEPENDENT NITROGLYCERINE MEDIATED DILATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYALURONIC ACID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; VASCULAR FUNCTION; BLOOD; BRACHIAL ARTERY; PATHOPHYSIOLOGY; VASODILATATION;

AGED; BIOLOGICAL MARKERS; BRACHIAL ARTERY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; VASODILATION;

EID: 84906343724     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2014.940502     Document Type: Article

References (24)

1. Adams MR, Robinson J, McCredie R, et al. (1998). Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 32: 123-7.
2. Ceriello A. (1998). The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet Med 15: 188-93.
3. Chajara A, Raoudi M, Delpech B, et al. (2000). Increased hyaluronan and hyaluronidase production and hyaluronan degradation in injured aorta of insulin-resistant rats. Arterioscler Thromb Vasc Biol 20: 1480-7.
4. Flammer AJ, Anderson T, Celermajer DS, et al. (2012). The assessment of endothelial function: from research into clinical practice. Circulation 126:753-67.
5. Heickendorff L, Ledet T, Rasmussen LM. (1994). Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque. Diabetologia 37: 286-92.
6. Henry CB, Duling BR. (1999). Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol 277: H508-14.
7. Imai E, Matsuo S, Makino H, et al. (2008). Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods. Hypertens Res 31:1101-7.
8. Kashiwagi A, Kasuga M, Araki E, et al; Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. (2012). International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int 31:8-10.
9. Lennon FE, Singleton PA. (2011). Hyaluronan regulation of vascular integrity. Am J Cardiovasc Dis 2011;1:200-13.
10. Levey AS, Coresh J, Greene T, et al. (2006). Chronic Kidney Disease Epidemiology Collaboration: using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247-54.
11. Mine S, Okada Y, Kawahara C, et al. (2006). Serum hyaluronan concentration as a marker of angiopathy in patients with diabetes mellitus. Endocr J 53:761-6.
12. Nieuwdorp M, Meuwese MC, Vink H, et al. (2005). The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol 16:507-11.
13. Nieuwdorp M, van Haeften TW, Gouverneur MC, et al. (2006a). Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55:480-6.
14. Nieuwdorp M, Mooij HL, Kroon J, et al. (2006b). Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 55:1127-32.
15. Nieuwdorp M, Holleman F, de Groot E, et al. (2007). Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis. Diabetologia 50:1288-93.
16. Onkelinx A, Cornelissen V, Goetschalckx K, et al. (2013). Reproducibility of different methods to measure the endothelial function. Vasculr Med 17:79-84.
17. Pardue EL, Ibrahim S, Ramamurthi A. (2008). Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering. Organogenesis 4:203-14.
18. Raitakari OT, Seale JP, Celermajer DS. (2001). Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis. Am J Cardiol 87:217-19.
19. Riessen R, Wight TN, Pastore C, et al. (1996). Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 93: 1141-7.
20. Sainio A, Jokela T, Tammi MI, Jarvelainen. (2010). Hyperglycemic conditions modulate connective tissue reorganization by human vascular smooth muscle cells through stimulation of hyaluronan synthesis. Glycobiology 20:1117-26.
21. Slevin M, Krupinski J, Gaffney J, et al. (2007). Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 26:58-68.
22. Stern R, Asari AA, Sugahara KN. (2006). Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85:699-715.
23. Teragawa H, Ueda K, Matsuda K, et al. (2005). Relationship between endothelial function in the coronary and brachial arteries. Clin Cardiol 28:460-6.
24. Vigetti D, Genasetti A, Karousou E, et al. (2010). Pro-inflammatory cytokines induce hyaluronan synthesis and monocyte adhesion in human endothelial cells through hyaluronan synthase 2 (HAS2) and the nuclear factor-kappaB (NF-kappaB) pathway. J Biol Chem 285:24639-45.